Showing 91 to 105 of 413 results
HCPC response to PSA Performance Review
HCPC welcomes recognition of progress on key areas of activity and sets out plan for further improvement
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)
What you need to know about being an expert witness
Being an expert witness is an opportunity to demonstrate high levels of expertise and professionalism in your own area of practise
CPD Week 2025 begins
Monday 3 March marks the start of the HCPC's first ever CPD Week. We will be showcasing resources, sharing good practice and publishing materials designed to support registrants with their CPD.
Paramedic programmes non-ambulance practice-based learning: Understanding our requirements
We have produced an information sheet for education providers to enable consideration of our regulatory requirements and standards when developing in this area.
Closure of the COVID-19 Temporary Register
The COVID-19 Temporary Register will close on the 31 March 2024.
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.